Skip to main content
Clinical Trials/IRCT20220822055771N1
IRCT20220822055771N1
Recruiting
Phase 3

? Comparative study of the effect of metformin and empagliflozin on cardiometabolic, anthropometric and hormonal factors in women with polycystic ovarian syndrom

Shahre-kord University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Polycystic ovarian syndrome.
Sponsor
Shahre-kord University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Shahre-kord University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • women between 15\-55 years old
  • polycystic ovarian syndrom

Exclusion Criteria

  • Glomerular filtration rate\<30
  • liver disease
  • diabet mellitus
  • urinary tract infection
  • chronic disease
  • on hypertention treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials